| ManagementTogether the founders, Udo Blaseg and Dr. Hakim Bouterfa, bring to the table >50 years of experience in the pharmaceutical and radiopharmaceutical industry and its principal business areas (clinical and business development, international marketing, business economics, European and US regulations, scientific studies, experiences and success as entrepreneurs). Hence, the founders have a unique combination of experience, knowledge and skills. |
|
|
|
Udo Blaseg
Managing Director
Head of Operations, Business Development, Marketing & Sales
Former Principal of Blaseg & Associates – Business Advisory in Radiopharmacy and Nuclear Medicine; Former Executive VP Business Development, Marketing & Sales at Isotope Products Europe Blaseg GmbH
|
|
|
|
Dr. Hakim Bouterfa
Managing Director
Head of Medical Affairs and Clinical Development
Former VP European Operations and Managing Director of Molecular Insight Pharmaceuticals GmbH; Former Global Medical Director for Sandostatin franchise of Novartis Pharma GmbH
|
|
|
| TeamThe OctreoPharm Sciences team members have backgrounds in the pharmaceutical, radiopharmaceutical or finance industry assuring a breadth of experience in all facets of pharmaceutical or radiopharmaceutical industry operations.
|
|
|
 |
Dr. Jens Kaufmann
Head of Radiopharmaceutical Development
Former manager of chemcical product and process development at Eckert & Ziegler AG; Former laboratory supervisor at ASCA-Berlin GmbH, contract research for pharmaceutical and chemical companies. |
|
|
|
Anna Steinbeck, M.Sc.
Head of Finance & Administration
Master of International Business & Master of Commerce with major Finance from the University of Sydney; A member of the Beta Gamma Sigma Honor Society for Business Administration.
|
